An open label study of the pharmacokinetics, safety and antiviral activity of Invirase boosted with ritonavir in HIV-infected infants and children 4 months to <6 years old.
Phase of Trial: Phase II
Latest Information Update: 11 Mar 2016
At a glance
- Drugs Saquinavir (Primary) ; Ritonavir
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Roche
- 10 Jun 2017 Biomarkers information updated
- 12 Jul 2011 New source identified and integrated (European Clinical Trials Database record, EudraCT2007-004617-34).
- 17 Aug 2010 Actual end date changed from May 2010 to Jun 2010 as reported by ClinicalTrials.gov.